Related Experiment Video
Updated: Aug 29, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
High-level penicillin-nonsusceptible Streptococcus pneumoniae bacteremia: identification of a low-risk subgroup
Jörg J Ruhe1, Leann Myers, David Mushatt
1Department of Medicine, Infectious Diseases Section, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Abstract:
High-level penicillin resistance has been associated with treatment failure in patients with Streptococcus pneumoniae infections. To identify a subgroup of patients at low risk for high-level penicillin-nonsusceptible S. pneumoniae bacteremia, a cross-sectional study of 303 patients was performed. For the total study population, penicillin resistance was observed in 98 (32%) of 303 patients; high-level resistance was seen in 33 (11%). A predictive model was created by using 3 baseline variables that were independently associated with high-level penicillin resistance: previous beta -lactam antibiotic use, previous stay in a risk area (defined as stay in day care facilities, prisons, homeless shelters, nursing homes, or other long-term care facilities), and previous respiratory tract infection. The model was used to identify patients at low and high risk for high-level penicillin-resistant pneumococcal bacteremia. None of the isolates of patients in the low-risk subgroup had ceftriaxone resistance. Patients in the low-risk subgroup could be empirically treated with fluoroquinolone-sparing regimens.
Insights
A predictive model identified patients at low risk for high-level penicillin-resistant Streptococcus pneumoniae bacteremia. This allows for fluoroquinolone-sparing antibiotic regimens in low-risk individuals.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- High-level penicillin resistance in Streptococcus pneumoniae is linked to treatment failure.
- Identifying patients at low risk for resistant bacteremia is crucial for effective treatment strategies.
Purpose of the Study:
- To develop a predictive model for identifying patients at low risk of high-level penicillin-nonsusceptible S. pneumoniae bacteremia.
- To guide empirical antibiotic treatment choices for pneumococcal bacteremia.
Main Methods:
- A cross-sectional study of 303 patients with S. pneumoniae infections was conducted.
- A predictive model was developed using baseline variables associated with high-level penicillin resistance.
- Patient subgroups were categorized as low-risk or high-risk based on the model.
Main Results:
- Penicillin resistance was observed in 32% of patients; high-level resistance in 11%.
- Previous beta-lactam antibiotic use, stay in a risk area, and respiratory tract infection were key predictors.
- No ceftriaxone resistance was found in the low-risk subgroup.
Conclusions:
- A validated predictive model can identify patients at low risk for high-level penicillin-resistant pneumococcal bacteremia.
- Low-risk patients may be suitable for empirical fluoroquinolone-sparing antibiotic regimens.
- This approach can help optimize antibiotic use and mitigate resistance development.
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Clinical Significance of Antibiotic Resistance

